Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)

Maurizio Battaglia Parodi, Pierluigi Iacono

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e29-e30
JournalOphthalmology
Volume126
Issue number4
DOIs
Publication statusPublished - Apr 2019

ASJC Scopus subject areas

  • Ophthalmology

Cite this